23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
2.420
-0.320 (-11.68%)
At close: Feb 21, 2025, 4:00 PM
2.500
+0.080 (3.31%)
After-hours: Feb 21, 2025, 7:20 PM EST
23andMe Holding Co. Employees
As of March 31, 2024, 23andMe Holding Co. had 582 total employees, including 560 full-time and 22 part-time employees. The number of employees decreased by 234 or -28.68% compared to the previous year.
Employees
582
Change (1Y)
-234
Growth (1Y)
-28.68%
Revenue / Employee
$358,720
Profits / Employee
-$670,742
Market Cap
64.92M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 582 | -234 | -28.68% |
Mar 31, 2023 | 816 | 48 | 6.25% |
Mar 31, 2022 | 768 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ME News
- 18 hours ago - Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million - CNBC
- 22 days ago - 23andMe Launches New Genetic Report on Osteoporosis - GlobeNewsWire
- 24 days ago - 23andMe is exploring strategic alternatives, looking to raise capital - CNBC
- 24 days ago - 23andMe Special Committee Announces Exploration of Strategic Alternatives - GlobeNewsWire
- 24 days ago - 23andMe Reports Third Quarter Fiscal Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - 23andMe Reportedly Considers Selling Lemonaid Telehealth Unit - PYMNTS
- 5 weeks ago - 23andMe has been quietly exploring a possible sale of its telehealth business, Lemonaid - Business Insider
- 6 weeks ago - 23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit's Trusted Technology - GlobeNewsWire